Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes

NCT00154414 · Completed

Last updated 2026-05-28

This clinical trial tested the effect of the medication liraglutide on blood sugar control in Japanese adults with type 2 diabetes.

Status Completed The study has finished.

Phase Phase 2 Tests whether it works and watches safety in a moderate group.

Type Interventional (clinical trial)

Design Randomized, double-blind treatment study

Participants 226 people

Who can join Ages 20–74 · all sexes

Timeline Started 2005-01 · est. completion 2006-05

Where 1 site · Japan

What this study is testing ClinicalTrials.gov NCT00154414 ↗

Description as written by the study sponsor.

This trial is conducted in Japan. The aim of this research trial is to evaluate the effect of treatment with liraglutide or placebo on blood glucose control after 14 weeks in Japanese subjects with type 2 diabetes. Liraglutide or placebo is administered by injection once daily in the evening. The trial is a multi-national trial with treatment concealed to participating subjects, investigators and the sponsor. Treatment allocation is random with equal chance of being assigned to each group.

Treatments tested

liraglutide Drug

Main thing measured	HbA1c
Sponsor	Novo Nordisk A/S
Conditions studied	Diabetes, Diabetes Mellitus, Type 2
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT00154414 ↗